ID: MRFR/HC/6746-CR | August 2019 | Region: Global | 101 pages
Market Overview
Global Orthokeratology Lens Market is expected to register a CAGR of 7.4% to reach USD 3,857.8 Million till 2025.
Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. It is a non-surgical method used to correct refractive errors by reshaping the curvature of the cornea to improve object visibility. This procedure is a temporary treatment method used for the correction of myopia, hypermetropia, and other eye-related problems.
The growing prevalence of refractive errors across the globe, advancements in the field of ophthalmology over the past couple of decades and low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is expected to enhance the market growth. However, the availability of alternative treatment methods and risk associated with orthokeratology are projected to curb the growth of the market.
Market Dynamics
A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods. Myopia is reported as the most common disorder affecting a large number of populations worldwide. The World Health Organization 2018 fact sheet estimated that approximately 1.3 billion people were living with some form of vision impairment. It also reported that 188.5 million patients have a mild vision impairment, 217 million people have moderate to severe vision impairment, and 36 million people are blind, globally. Such a vast population suffering from eye problems boosts market growth during the forecast period.
Global Orthokeratology Lens Market Share, by Application, 2018 & 2025 (USD MILLION)
Source: MRFR Analysis
Segmentation
The global orthokeratology lens market, by material, has been segmented into silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. On the basis of application, the global orthokeratology lens market has been segmented into myopia and hyperopia. Based on end user, the market has been segmented into hospitals and ophthalmic clinic.
Regional Analysis
The global orthokeratology lens market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to hold the largest share of the global orthokeratology lens market. The growth of the Americas can be attributed to its rising geriatric population and increasing ophthalmological disorders, causing an increased need for diagnosis and therapeutics.
Asia-Pacific is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are the rising patient population of people with eye disorders, availability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the presence of good healthcare infrastructure. According to the Asian Development Bank, the elderly population in Asia is projected to reach nearly 923 million by 2050.
Europe is estimated to be growing at the fastest pace in the global market due to the increasing cases of eye disorders and increasing government initiatives are driving the growth of the market. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired.
The orthokeratology lens market in the Middle East & Africa is expected to exhibit the least growth in the global orthokeratology lens market due to factors such as limited access to healthcare affordability issues.
Key Players
The prominent players in the global orthokeratology lens market are Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Procornea (CooperVision) (Eerbeek, Netherlands), Euclid Systems Corporation (Virginia), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas) and CONTAMAC (Essex).
Some of the key strategies followed by players operating in the global orthokeratology lens market were innovation, product development, and acquisition & mergers.
Market Segmentation
Global Orthokeratology Lens Market, by Material
Global Orthokeratology Lens Market, by Application
Global Orthokeratology Lens Market, by End User
Global Orthokeratology Lens Market, by Region
Available Additional Customizations
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size |
|
CAGR | 7.4% (2018-2025) |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Material, Application, End User and Region |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Procornea (CooperVision) (Eerbeek, Netherlands), Euclid Systems Corporation (Virginia), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas) and CONTAMAC (Essex). |
Key Market Opportunities |
|
Key Market Drivers | A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods. |
Frequently Asked Questions (FAQ) :
The orthokeratology lens market is projected to grow at a 7.4% CAGR between 2016-2025.
The Americas are expected to lead the orthokeratology lens market.
The orthokeratology lens market is predicted to touch USD 3,857.8 million by 2025.
Leading players profiled in the orthokeratology lens market include CONTAMAC (Essex), Alcon, Inc. (Texas), Brighten Optix (Taiwan), Visioneering Technologies, Inc. (VTI) (Georgia), Euclid Systems Corporation (Virginia), Procornea (CooperVision) (Eerbeek, Netherlands), Menicon Co., Ltd (Japan), CE GP Specialists (US), CooperVision (US), and Bausch & Lomb Incorporated (US).
Key strategies followed by industry players to maintain dominance in the orthokeratology lens market include acquisition and mergers, product development, and innovation.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.